Literature DB >> 1271695

[Dietary problems in the management of type I hyperlipoproteinemia (author's transl)].

A D Rakow, H U Klör, D Leupold, H H Ditschuneit, H Ditschuneit, H J Bremer.   

Abstract

The therapeutic effect of different diets varying in long chain and medium chain triglycerides, carbohydrate, and protein was tested in two siblings with type I hyperlipoproteinemia. Despite administration of an extremely fat reduced diet ( less than 5 g daily), a normalization of plasma TG could not be obtained because-as a consequence of its high carbohydrate and/or its MCT content-it resulted in a considerable increase in pre-beta-lipoproteins. As life long dietary therapy has to be maintained, the risks of a normal therapy has to be maintained, the risks of a normal fat containing diet (mainly bouts of pancreatitis) and those of a carbohydrate and MCT rich diet (premature atherosclerosis) are to be carefully considered. On the basis of our data we therefore suggest the following dietary regimen: 1. Reduced intake of long chain triglycerides (less than 30 gms per day), but with sufficient amounts of essential fatty acids (4-6 gms linoleate daily). 2. The carbohydrates should not exceed 50% of total calories and ought to consist mainly of starch. 3. The caloric deficit thus generated should be balanced by a high protein intake. This is faciliated by applying a specially protein-enriched food. 4. Medium chanin triglycerides may be necessary when adherence to the protein-rich diet turns out to be bad.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1271695     DOI: 10.1007/BF01470927

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  26 in total

1.  HYPERGLYCERIDEMIA RESULTING FROM INTAKE OF MEDIUM CHAIN TRIGLYCERIDES.

Authors:  H Uzawa; G Schlierf; S Chirman; G Michaels; P Wood; L W Kinsell
Journal:  Am J Clin Nutr       Date:  1964-12       Impact factor: 7.045

2.  A genetic and metabolic study of a family with hyperlipemia.

Authors:  G BIALKIN; S ZUCKER; B S SKLARIN; K HIRSCHHORN; M DAVIDSON
Journal:  Pediatrics       Date:  1962-04       Impact factor: 7.124

3.  Microdetermination of long-chain fatty acids in plasma and tissues.

Authors:  V P DOLE; H MEINERTZ
Journal:  J Biol Chem       Date:  1960-09       Impact factor: 5.157

4.  Relationship between relapsing pancreatitis and essential hyperlipemia.

Authors:  G KLATSKIN; M GORDON
Journal:  Am J Med       Date:  1952-01       Impact factor: 4.965

5.  Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man.

Authors:  J D Brunzell; W R Hazzard; D Porte; E L Bierman
Journal:  J Clin Invest       Date:  1973-07       Impact factor: 14.808

6.  [Family studies in hyperlipoproteinemia type I].

Authors:  H Ditschuneit; H J Bremer; M Eckart; J D Faulhaber; G Hiller; U Klör; A D Rakow; H J Thun
Journal:  Verh Dtsch Ges Inn Med       Date:  1972

7.  Acquired type I hyperlipoproteinemia with systemic lupus erythematosus, dysglobulinemia and heparin resistance.

Authors:  C J Glueck; R I Levy; H I Glueck; H R Gralnick; H Greten; D S Fredrickson
Journal:  Am J Med       Date:  1969-08       Impact factor: 4.965

8.  Hydrolysis of diglyceride and glyceryl monoester diethers with "lipoprotein lipase".

Authors:  H Greten; R I Levy; H Fales; D S Fredrickson
Journal:  Biochim Biophys Acta       Date:  1970-06-09

9.  [Studies of a clinical case of fat-induced (exogenous) hypertriglyceridemia].

Authors:  H Braunsteiner; H Berger; S Sailer; F Sandhofer
Journal:  Schweiz Med Wochenschr       Date:  1968-03-23

10.  Plasma lipids in human linoleic acid deficiency.

Authors:  F D Collins; A J Sinclair; J P Royle; D A Coats; A T Maynard; R F Leonard
Journal:  Nutr Metab       Date:  1971       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.